Skip to main content

Find Clinical Trials

Home
Conditions
HER 2 Low-expressing Breast Cancer

Clinical trial condition

HER 2 Low-expressing Breast Cancer

Explore clinical trials studying HER 2 Low-expressing Breast Cancer. Study availability and eligibility vary by location and protocol.

4 public trials 1 recruiting study

Refine in advanced search Browse all conditions

HER 2 Low-expressing Breast Cancer trial results

Recruiting

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

NCT06828588

Conditions: Breast Diseases, Breast Neoplasms, Carcinoma, +27 more
Locations: Vanderbilt University Medical Center Nashville, Tennessee, United States

View Trial Details

Not Yet Recruiting

PERCIST Evaluation of Trastuzumab Deruxtecan in the Treatment of HER2 Low Breast Cancer

NCT07130344

Conditions: Breast Diseases, Breast Neoplasms, HER 2 Low-expressing Breast Cancer, +5 more
Locations: ICANS Strasbourg, France

View Trial Details

Not Yet Recruiting

Testing Two Different Drugs (Sacituzumab-govitecan and Trastuzumab-deruxtecan) Combinations Prescribed in an Alterning Pattern to Patients With Metastatic or Locally Advanced Triple-negative Breast Cancer

NCT07151586

Conditions: Breast Diseases, Breast Neoplasms, HER 2 Low-expressing Breast Cancer, +9 more
Locations: institut Paoli calmette Marseille, France

Gustave Roussy Villejuif, France

View Trial Details

Not Yet Recruiting

Correlation Study of Serum HER 2 Against HER 2-ADC Drug Efficacy in HER 2 Low-expressing Breast Cancer

NCT06492447

Conditions: HER 2 Low-expressing Breast Cancer
Locations: Not specified

View Trial Details